Palisade Bio Inc (PALI)

Apr 03, 2026

Palisade Bio (PALI) reports positive phase 1b data for PALI-2108 in UC patients - MSN

Apr 03, 2026

Apr 02, 2026

Palisade Bio partners with Iterative Health to advance PALI-2108 - TipRanks

Apr 02, 2026

Apr 02, 2026

Palisade Bio enters agreement with Iterative Health and completes $3 million stock sale - Investing.com

Apr 02, 2026

Apr 02, 2026

Palisade Bio raises $3.0M from Iterative Health affiliate to support PALI-2108 Phase 2 enrollment - TradingView

Apr 02, 2026

Apr 02, 2026

Palisade Bio (NASDAQ: PALI) sells 1.54M shares to Iterative Health affiliate - stocktitan.net

Apr 02, 2026

Apr 01, 2026

Palisade Bio, Inc. (PALI) stock price, news, quote and history - Yahoo Finance UK

Apr 01, 2026

Apr 01, 2026

Clear Street Maintains Palisade Bio(PALI.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Apr 01, 2026

Apr 01, 2026

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Edwards Lifesciences (EW) and Palisade Bio (PALI) - The Globe and Mail

Apr 01, 2026

Mar 31, 2026

Clear Street reiterates Palisade Bio stock rating on trial data By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

Update: Palisade Bio Shares Fall After Phase 1b Data on PALI-2108 in Fibrostenotic Crohn's Disease - moomoo.com

Mar 31, 2026

Mar 31, 2026

Clear Street reiterates Palisade Bio stock rating on trial data - Investing.com

Mar 31, 2026

Mar 31, 2026

Palisade Bio Shares Fall After Phase 1b Data on PALI-2108 in Fibrostenotic Crohn's Disease - marketscreener.com

Mar 31, 2026

Mar 31, 2026

Palisade Bio Shares Phase 1b PALI-2108 Data Showing Safety, PK and Early Crohn’s Efficacy Signals - MarketBeat

Mar 31, 2026

Mar 31, 2026

Support Test: Can Palisade Bio Inc beat the S P 500Market Growth Summary & Weekly Momentum Picks - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

Palisade Bio posts trial data for lead asset (PALI:NASDAQ) - Seeking Alpha

Mar 31, 2026

Mar 31, 2026

Crafting a New Financial Era: Palisade Bio Inc.’s Strategic Moves - StocksToTrade

Mar 31, 2026

Mar 31, 2026

Palisade Bio stock maintains buy rating at Stifel on trial data - Investing.com Canada

Mar 31, 2026

Mar 31, 2026

Palisade Bio stock maintains buy rating at Stifel on trial data By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

H.C. Wainwright Maintains Palisade Bio(PALI.US) With Buy Rating, Maintains Target Price $7 - moomoo.com

Mar 31, 2026

Mar 31, 2026

Palisade Bio reports Phase 1b trial results for Crohn’s drug By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 30, 2026

Palisade Bio reports Phase 1b trial results for Crohn’s drug - Investing.com

Mar 30, 2026

Mar 30, 2026

After 2 weeks, Palisade’s Crohn’s pill showed no serious side effects - stocktitan.net

Mar 30, 2026

Mar 30, 2026

HC Wainwright Forecasts Palisade Bio Q1 Earnings - MarketBeat

Mar 30, 2026

Mar 27, 2026

Palisade Bio Inc. (PALI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Mar 27, 2026

Mar 27, 2026

PALI Should I Buy - Intellectia AI

Mar 27, 2026

Mar 26, 2026

HC Wainwright Begins Coverage on Palisade Bio (NASDAQ:PALI) - marketbeat.com

Mar 26, 2026

Mar 24, 2026

Big Picture: Can Palisade Bio Inc expand its profit marginsMarket Performance Summary & Free Accurate Trade Setup Notifications - baoquankhu1.vn

Mar 24, 2026

Mar 23, 2026

PALI SEC FilingsPalisade Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 23, 2026

Mar 23, 2026

Palisade Bio: Undervalued Biotech With Blockbuster Potential, Initiating With A Speculative Buy Rating - Seeking Alpha

Mar 23, 2026

Mar 21, 2026

Palisade Bio 2026 10-K: Clinical Development, Risk Factors, and Precision Medicine Strategies for IBD - Minichart

Mar 21, 2026

Mar 21, 2026

Aug Spikes: Can Palisade Bio Inc expand its profit marginsQuarterly Earnings Report & Weekly Return Optimization Alerts - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

Palisade Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 20, 2026

Mar 20, 2026

Palisade Bio (NASDAQ:PALI) Issues Quarterly Earnings Results, Beats Estimates By $1.10 EPS - MarketBeat

Mar 20, 2026

Mar 20, 2026

Palisade Bio Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 20, 2026

Mar 20, 2026

Palisade Bio 10-K: Net loss $16.8M, EPS $(0.30) - TradingView

Mar 20, 2026

Mar 20, 2026

[10-K] PALISADE BIO, INC. Files An... - Stock Titan

Mar 20, 2026

Mar 18, 2026

Palisade Bio (PALI) Reports Positive Phase 1b Data for PALI-2108 in UC Patients - Insider Monkey

Mar 18, 2026

Mar 18, 2026

PALI Q4'25 Earnings: revenue estimate is 0 USD - TradingView

Mar 18, 2026

Mar 17, 2026

Day Trade: Can Palisade Bio Inc beat the S P 500Bear Alert & Stepwise Trade Execution Plans - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 17, 2026

Mar 16, 2026

Palisade Bio (PALI) Expected to Announce Quarterly Earnings on Monday - MarketBeat

Mar 16, 2026

Mar 12, 2026

Palisade Bio (PALI) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 12, 2026

Mar 11, 2026

RSI Check: Will Palisade Bio Inc outperform its industry peers2026 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn

Mar 11, 2026

Mar 07, 2026

Aug Macro: Can Palisade Bio Inc maintain sales growth2025 Buyback Activity & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

Published on: 2026-03-07 13:46:23 - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

US Market Recap: Will Palisade Bio Inc stock recover after earningsTrade Volume Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

PALI Earnings History & Surprises | EPS & Revenue Results | PALISADE BIO INC (NASDAQ:PALI) - ChartMill

Mar 05, 2026

Mar 05, 2026

Treasury Yields: Will Palisade Bio Inc benefit from current market trends2025 Winners & Losers & Community Consensus Trade Signals - baoquankhu1.vn

Mar 05, 2026